English EN Spanish ES French FR Chinese (Simplified) ZH-CN
Print Friendly, PDF & Email

NCT/Study#

NA /

SALA-002-EW16

Phase 1 Trial of the LSD1 Inhibitor Seclidemstat (SP 2577) With and Without Topotecan and Cyclophosphamide in Patients With Relapsed or Refractory Ewing Sarcoma and Select Sarcomas

DISEASE GROUP:
Skin and Soft Tissue
current phase:
NA
STUDY STATUS:
Active
Location:
Hackensack, NJ
For More information: